CELH
Celsius Holdings, Inc.
CELH has the edge over DMC overall, supported by stronger modeled upside and stronger fundamentals.
DMC
Del Monte Corporation
DMC trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DMC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
DMC's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over DMC in the historical PE scenario, which offers more potential upside but is not a forecast.
DMC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $19.21 | -30% |
| Current | 16x | $27.43 | — |
| Fair | 20x | $34.18 | +25% |
| Forward | 32x | $27.43 | — |
| Expensive | 42x | $71.49 | +161% |
Historical ranges are pointers, not guarantees.
DMC's PE is in its fair range at 16x. Analysts expect earnings to fall, which would put today's price at 32x next year's earnings, in its expensive range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over DMC on the outlook, with more favorable valuation and earnings expectations.
DMC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Growth | |
| -- | |
| Limited | |
| -- |
Analysts expect DMC's revenue to grow, but its earnings to decline.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
DMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.85 | -50% |
| Q3 2026 | $1.71 | +5.6% |
| Q2 2026 | $0.71 | -77% |
| Q1 2026 | $1.45 | -52% |
| Q4 2025 | $1.88 | -36% |
| Q3 2025 | $1.62 | +376% |
| Q2 2025 | $3.11 | +$3.48 |
| Q1 2025 | $3.05 | +$3.55 |
| Q4 2024 | $2.96 | +$3.20 |
DMC has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over DMC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over DMC on profitability, with a higher operating margin.
DMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +7.2% |
| Q2 2026 | $1.2B | +3.1% |
| Q1 2026 | $1B | -4.9% |
| Q4 2025 | $1B | +0.6% |
| Q3 2025 | $1B | +0.2% |
| Q2 2025 | $1.2B | +3.8% |
| Q1 2025 | $1.1B | -0.9% |
| Q4 2024 | $1B | +0.5% |
DMC's revenue has held roughly level: $1.1B last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | +4.8 points |
| Q2 2026 | 2.8% | -3 points |
| Q1 2026 | 1.9% | -2.2 points |
| Q4 2025 | 4.5% | +1.5 points |
| Q3 2025 | -2.1% | -7.4 points |
| Q2 2025 | 5.8% | -0.2 points |
| Q1 2025 | 4.1% | +0.1 points |
| Q4 2024 | 3% | +14 points |
DMC's operating margin was 2.7% last quarter, up 4.8 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over DMC on cash generation, producing positive trailing cash flow while its opponent burns cash.
DMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$69.9M | -215% |
| Q2 2026 | $24.1M | -76% |
| Q1 2026 | $29.7M | -18% |
| Q4 2025 | -$17.2M | +$5.1M |
| Q3 2025 | $60.9M | +102% |
| Q2 2025 | $101.5M | -13% |
| Q1 2025 | $36.1M | +502% |
| Q4 2024 | -$22.3M | -$3.1M |
DMC's free cash flow was −$33M over the past year, against $176M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
DMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -256K shares |
| 1 year | -1.2% | -568K shares |
| 3 years | -1.9% | -912K shares |
| 5 years | -0.8% | -394K shares |
| Available history | -2.2% | -1M shares |
DMC has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $16.1M |
| Q1 2026 | $4M |
| Q4 2025 | $15M |
| Q3 2025 | $7.2M |
| Q2 2025 | — |
| Q1 2025 | $7.6M |
| Q4 2021 | — |
DMC spent $35M buying back its own shares over the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over DMC on leverage, with a lower net debt burden relative to earnings.
DMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.8x | Very low |
DMC's net debt is about 2.4 years of its operating earnings (EBITDA), up from less than a year a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
DMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.5 | Neutral |
| Stochastic | 16.6 | Oversold |
DMC's weekly RSI is 34 (neutral) and its Stochastic is 17 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
DMC PE vs Consumer Defensive Sector
| Metric | DMC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 19x | 18% below |
| PE % | 39 | 18 | 21 pts above |
DMC has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over DMC on trend strength, trading above more of its moving averages.
DMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.9 | 5.1% below |
| 20 week MA | $29.7 | 7.5% below |
| 50 week MA | $34.3 | 20% below |
| 100 week MA | $33.9 | 19% below |
| 200 week MA | $30.3 | 9.5% below |
DMC is in a downtrend: it's below all five of its weekly moving averages, and 9.5% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
DMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.1 | $25.0 | -29% |
| 2021 | $25.0 | $27.4 | +9.6% |
| 2022 | $27.4 | $26.1 | -4.7% |
| 2023 | $26.1 | $26.3 | +0.5% |
| 2024 | $26.3 | $33.1 | +26% |
| 2025 | $33.1 | $35.9 | +8.4% |
| 2026 YTD | $35.9 | $27.4 | -24% |
DMC has the edge over CELH on returns for 2026, with the stronger performance.